Description
LHC-165 is a benzonaphthyridine TLR7 agonist.
Product Unit Size | Cost | Quantity | Stock |
---|
LHC-165 is a benzonaphthyridine TLR7 agonist.
Cas No. | 1258595-14-0 |
---|---|
Purity | ≥99% |
Formula | C29H32F2N3O7P |
Formula Wt. | 603.56 |
IUPAC Name | 3-[5-amino-2-[2-[4-[2-(3,3-difluoro-3-phosphonopropoxy)ethoxy]-2-methylphenyl]ethyl]benzo[f][1,7]naphthyridin-8-yl]propanoic acid |
Synonym | LHC165 |
Appearance | Pale yellow powder |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
Info Sheet |
---|
Zawit M, Swami U, Awada H, et al. Current status of intralesional agents in treatment of malignant melanoma. Ann Transl Med. 2021 Jun;9(12):1038. PMID: 34277838
Endogenous peptide, produced by activation of P...
Carotenoid found in shrimp, salmon, and algae.<...
Synthetic progestogen, orexigenic.
Pt-based DNA cross-linker.
Polyphenolic compound present in black tea.
p110α PI3K, DNA-PK, mTOR, Abl, Hck, Src, VEGFR...
CRM1-selective inhibitor of nuclear export.
Antitumor
Synthetic isoflavone.
Inhibitor of EGFR.
μOR and δOR agonist, D2/D3 DA potentiator.
mAChR agonist, selective for M2.
DNA alkylator.
O-methylated coumarin; Ca2+ channel blocker.
Statin; HMG-CoA reductase inhibitor.
benzophenanthridine alkaloid found in Chelidoni...
Steroid; glucocorticoid agonist.
Rifamycin derivative, induces pore formation in...
Induces cardiomyogenic effects in pluripotent c...
Synthetic peptide hormone, met-enkephalin analo...